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The association between baseline quadriceps strength and worsening of
WOMAC function score
Sex N Per Tertile
(% with
Progression)
Tertile of
Strength
Odds
Ratio
95% CI p-value
Men 274 (6.5) High (Referent)
277 (5.5) Middle 0.69 (0.32, 1.46) 0.3145
277 (6.1) Low 0.68 (0.34, 1.42) 0.3241
Women 437 (4.4) High (Referent)
432 (4.2) Middle 0.97 (0.49, 1.92) 0.9308
425 (6.4) Low 1.58 (0.82, 3.03) 0.1685
Conclusions: Quadriceps weakness was not associated with an increased
risk for worsening of knee pain severity or worsening self-reported
physical function over 30 months in either men or women. For the goals
of minimizing risk for impairments and functional limitations, these
data do not appear to support the importance of maintaining adequate
quadriceps strength in men and women with or at increased risk for
knee OA.
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SERUM OPIOID MONITORING IN OSTEOARTHRITIS PATIENTS WITH
CHRONIC PAIN: THE SEARCH FOR SENSITIVE BIOMARKERS
Y. Savitskaya, C. Duarte, N. Marin, R. Tellez, A. Alfaro, A. Izaguirre,
E. Villalobos, A. Almazan, C. Ibarra. Natl. Inst. of Rehabilitation, Mexico,
Mexico
Background: Osteoarthritis (OA), a common, minimally inﬂammatory
rheumatological syndrome characterized by chronic joint pain and
dysfunction, the primary symptom of OA is pain that is seen as entirely
linked with function, with physical movements triggering pain, while
pain, in turn, causes limitations in physical function. Chronic pain has
been associated with augmented circulating catecholamines (CAs) and
bradykinin. The presence of natural antibodies (NA) regarding speciﬁcity
and have gained increasing attention in proteome analysis for developing,
monitoring and effective treatment of OA.
Objectives: The objective of the study was to test of natural antibodies
against serum proteins relevant to pain (dopamine DA, adrenaline AD,
noradrenaline NA, bradykinin BK) expression on chronic osteoarthritis
pain.
Methods: We evaluated 75 individuals with chronic pain (>3 months)
due to OA. Pain was moderate to severe (>4 of 10), as self-assessed with
Likert scale (0 to 10) using a daily pain diary for 2 wk before outpatient
screening assessment. The clinical diagnosis of OA was further conﬁrmed
using Kellgren and Lawrence radiographic scoring criteria. 75 healthy
individuals without OA or other pain syndromes, of similar age and
body mass index (BMI), were evaluated as control subjects Table 1. We
compared circulating concentrations of NA against CAs, BK in the using
express ELISA protocol (INR).
Results: We detected signiﬁcantly higher concentrations of DA-IgG and
BK-IgG in OA patients compared with healthy control. In addition, we
found signiﬁcant relationships between serum DA-IgG and BK-IgG in
patients with chronic, moderate to severe OA pain. Elevated DA-IgG
was signiﬁcantly correlated with BK-IgG (r = 0.91; P < 0.005) and VAS
(r = 0.75; P < 0.001) in OA patients. There were no statistically signiﬁcant
differences in mea values for NA to AD and NA in OA patients, compared
with healthy control subjects.
Conclusions: Evaluated together DA-IgG and BK-IgG, they can give
important information about immune system functioning, especially
relating to pain and vascular homeostasis. High throughput technology
has made major contributions to the study autoantigen-antibody systems
as serological markers of pain in OA. Quick and easy to perform ELISA test
for detect DA-IgG/BK-IgG can be routinely used in clinical laboratories.
Our results have potential applications for controlling unwanted pain
and future response to therapy in OA patients.
Table 1. Baseline characteristics
Age (yr) 54±8.8 51±11.1
BMI (kg/m2) 26±2.5 26±3.3
Duration of OA (yr) 13.0±9.8
Pain (visual analog) scores 5.46±2.15 0.00±0.00
Beck Depression Index 5.56±5.69 1.00±1.86
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OSTEOPONTIN LEVEL IN SYNOVIAL FLUID IS ASSOCIATED WITH THE
SEVERITY OF KNEE JOINT PAIN
M. Yamaga, K. Tsuji, K. Miyatake, J. Yamada, I. Sekiya, T. Muneta. Tokyo
Med. and Dental Univ., Tokyo, Japan
Purpose: Osteopontin (OPN) is an O-glycosylated phosphoprotein which
is synthesized in a variety of tissues and cells including chondrocytes and
synoviocytes. Accumulating data indicated that OPN is involved in the
process of inﬂammation, immunity, and bone metabolism. OPN knockout
mice have already been created and shown that cartilage degradation
is accelerated in the absence of OPN. Human studies revealed that OPN
protein level increased in the synovial ﬂuid from the patients suffering
from OA and RA. These data strongly suggest that OPN is involved in joint
homeostasis and in the pathogenesis of arthritis. However, the molecular
functions of OPN in these processes are not yet extensively studied. Here
we report that synovial ﬂuid OPN level is associated with the severity of
joint pain.
Methods: This study was approved by the Ethics Committee of
this institute. All patients included in this study gave their full,
written, informed consent for participation prior to the operative
procedure. Tissue samples (synovial ﬂuid and synovial membrane)
were obtained from the patients who underwent anterior cruciate
ligament reconstruction (ACL-R) or total knee arthroplasty (TKA) from
January 2009 till October 2010 in our hospital (OA: 27 samples,
female: 22 male: 5, range 51–90 year-old, average 77 year-old, ACL-R: 17
samples, female: 4 male: 13, range 18–47 year-old, average 27 year-old).
OPN mRNA expressed in synovial membrane was quantiﬁed by RT-QPCR
(Roche, Light Cycler 480, Germany). Total OPN protein levels in synovial
ﬂuid were quantiﬁed using OPN/OPN N-half ELISA kit (IBL, Japan) and
compared them with clinical parameters such as Lysholm score (ACL-R),
visual analogue scale (VAS, TKA), serum C-reactive protein (CRP) level,
and macroscopic observation of cartilage degradation.
Results and Discussion: As previously reported, OPN mRNA expression
level in synovial membrane and OPN protein level in synovial ﬂuid were
signiﬁcantly increased in OA if compared with those of ACL-R.
In the ACL-R group, OPN protein level in synovial ﬂuid was gradually
decreased after the injury. We found that OPN protein level in
synovial ﬂuid was POSITIVELY associated with the severity of joint
pain (Lysholm Score) although it was not statistically signiﬁcant. Since
OPN acts as a pro-inﬂammatory cytokines by enhancing migration,
survival, phagocytosis, and pro-inﬂammatory cytokine production of
macrophages, we hypothesized that OPN induces joint pain by promoting
inﬂammation in the joint. To test this hypothesis, we investigated the
correlation of OPN protein level in synovial ﬂuid with serum CRP level.
However, we did not observe any correlation between these two. Further
analysis is required to elucidate if our hypothesis is correct or not.
Since accelerated degradation of articular cartilage is observed in OPN
knockout mice, we next investigated the correlation of OPN protein
level in synovial ﬂuid with the macroscopic observation of cartilage
degradation. However, we also did not observe any correlation between
these two parameters.
In the TKA group, most interestingly, OPN protein level in synovial ﬂuid
was NEGATIVELY correlated with the severity of joint pain (VAS) in
OA patients (R = −0.469) but not with the serum CRP level by Pearson
product-moment correlation coefﬁcient analysis. These data represent
stark contrast to those of ACL-R group, and further analyses is required
to elucidate the roles of OPN in the regulation of knee joint pain.
Conclusions: Osteopontin level in synovial ﬂuid was associated with the
severity of joint pain. In the ACL-R group, it is POSITIVELY associated
with the severity of joint pain, however, NEGATIVELY correlated in the
TKA group.
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IDENTIFYING PAIN VULNERABILITY PHENOTYPES IN
OSTEOARTHRITIS
A.E. Nelson1, R.F. DeVellis1,2, B.M. DeVellis2, Y.M. Golightly1,
W. Maixner3,4, J.M. Jordan1. 1Univ. of North Carolina, Thurston Arthritis
Res. Ctr., Chapel Hill, NC, USA; 2Univ. of North Carolina, Gillings Sch. of
Global Publ. Hlth., Dept. of Hlth.Behavior and Hlth.Ed., Chapel Hill, NC, USA;
3Univ. of North Carolina, Sch. of Med., Dept of Endodontics, Chapel Hill, NC,
USA; 4Univ. of North Carolina, Dept. of Pharmacy, Chapel Hill, NC, USA
Purpose: Joint symptoms do not correlate perfectly with structural
damage in osteoarthritis (OA), and it is known that psychosocial issues,
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such as depression, can increase an individual’s experience of pain. We
used factor analysis to determine the relationships among symptomatic
and psychosocial variables in a community-based sample with and
without OA.
Methods: We used data from individuals who were both enrolled in
both the Johnston County OA Project and the separately funded Arthritis,
Coping, & Emotion (ACE) study (data collected 1999–2005, n = 2239). This
sample was approximately 1/3 male and African American, with mean
age of 65±11 years, body mass index 30±7kg/m2, and 13±11 years of
education. Half had radiographic OA (deﬁned as a Kellgren-Lawrence
grade ≥2) of at least one hip or knee. Symptomatic data were available
for 9 joint sites: the lower back and bilateral hands, knees, hips, and feet,
and were graded as none, mild, moderate, or severe “on most days.” The 7
validated psychosocial scales used were: the Centers for Epidemiological
Studies Depression Scale (CES-D), Positive and Negative Affect Scale
(PANAS), Rheumatology Attitudes Index (RAI), Social Support, Pain
Catastrophizing Helplessness Subscale, Arthritis Impact Measurement
Scale 2 Tension and Anxiety Subscale (AIMS2), and Life Orientation
Test (LOT). Symptomatic data and the 7 scales were individually factor
analyzed and appropriate composite scores were constructed. Higher
order factor analysis was used to determine the relationships among
these 8 composite scores. Cronbach’s alpha was calculated as a measure
of reliability and internal consistency. Analyses stratiﬁed by gender, race
(African American vs. Caucasian), age (<55, 55–65, 65–75, 75+ years),
body mass index (BMI, <25, 25 to <30, 30+ kg/meter squared), education
(less than, equal to, or more than 12 years) and by radiographic OA
status in the hip or knee were performed to determine any subgroup
differences.
Results: Analysis of each of the individual scales resulted in a single
factor (all alphas >0.79) with the exception of the PANAS, which, as
expected, had 2 factors (alpha 0.90) reﬂecting positive and negative affect
characteristics. Symptoms from 9 joint sites also loaded onto a single
factor (alpha 0.86). Higher order factor analysis using composite scores
for each of these factors produced a single factor with an eigenvalue
of 3.73 (See ﬁgure, due to missing values in individual scales, n = 1332,
loadings 0.40–0.88, alpha 0.84). Dropping each score individually did not
substantially change the alpha. Consistent results (factor loading pattern
and alpha) were obtained when stratiﬁed by gender, race, age, BMI,
education, or OA status.
Figure: Screeplot of higher order factor and table of loadings of each scale
onto this factor. *The eigenvalue represents the amount of information
contained in a factor, while loadings represent the association between
the individual scores and the factor.
Conclusions: This analysis suggests that there is a single latent variable
underlying musculoskeletal symptoms and a variety of psychosocial
variables representing depression, anxiety, optimism, social support, and
helplessness. The results were similar for subgroups of gender, race, age,
BMI, education, and radiographic OA status. Addressing psychosocial
components of the pain experience will be important for successful
treatment in conditions leading to chronic musculoskeletal pain, such as
OA.
6
A NOVEL TECHNOLOGY TO DECREASE KNEE PAIN AND JOINT LOAD
IN EARLY-ONSET KNEE OSTEOARTHRITIS
J. Takacs1, J.R. Leiter2,3, J.D. Peeler1,3. 1Dept. of Human Anatomy and Cell
Sci., Univ. of Manitoba, Winnipeg, MB, Canada; 2Dept. of Human Anatomy
and Cell Sci., Dept. of Surgery, Univ. of Manitoba, Winnipeg, MB, Canada;
3Pan Am Clinic, Winnipeg, MB, Canada
Purpose: To examine the effect of un-weighted exercise on knee pain
and knee loading in an overweight early-onset knee osteoarthritis (OA)
population. Research has demonstrated that body weight is the number
one modiﬁable risk factor associated with the onset and progression of
knee OA. However, exercise programs that aim to initiate weight loss and
improve pain and function in knee OA often increase loading on the knee
joint, contributing to exacerbation of symptoms and progression of the
disease. The introduction of a new treadmill that allows the participant to
walk un-weighted (the G-Trainer, Alter-G Inc., Menlo Park CA), utilizes a
technology called Lower Body Positive Pressure (LBPP), and now enables
our research team to study the relationship between body weight, knee
pain and knee loading via knee acceleration during exercise.
Methods: Participants with radiographically-conﬁrmed early-onset knee
OA were recruited to walk on the treadmill for a period of 25 minutes
at a speed of 1.4m/s. Subjects completed two walking sessions (one full
weight-bearing and one un-weighted session), which occurred 1 week
apart and were randomized in order. Subjects also completed two full
weight-bearing walking sessions (at a self-selected speed) on a walkway.
Measures included knee pain (via Visual Analog Scale) and knee joint
acceleration (via tri-axial accelerometry).
Results: Twenty-two overweight/obese patients (mean (SD) age
53.7 (5.9) yrs; mean (SD) BMI 33.6 (6.4) kg/m2) completed the treadmill
and walkway walking sessions. The mean level of un-weighting for
pain relief was 12.3% of body weight. There was a signiﬁcant difference
in knee pain between full weight-bearing treadmill walking and un-
weighted treadmill walking sessions (p < 0.05). Higher levels of un-
weighting during treadmill walking resulted in lower levels of knee
acceleration (p < 0.05). Similar speeds were seen for treadmill walking
and fast walking on the walkway; however knee acceleration was
signiﬁcantly lower during treadmill walking (p < 0.05).
Conclusions: A mean un-weighting of 12.3% of body weight was
sufﬁcient to decrease subjects’ pain while attenuating knee joint
acceleration. This level of weight loss (12% of body weight) is a realistic
value for overweight/obese patients suffering from knee pain due to knee
OA. The LBPP technology used by the G-trainer treadmill may help to
conserve the joint by limiting knee acceleration, while allowing patients
to successfully complete exercise programs targeting weight loss and
improved function. Future research should be directed at establishing
the efﬁcacy of this technology in the treatment of knee OA and other
musculoskeletal disorders of the lower extremity.
Funding was provided by the Canadian Institutes of Health Research and
the Dr. Paul H.T. Thorlakson Foundation Fund.
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PROGNOSIS OF CARTILAGE LOSS BY ANALYZING MAGNETIC
RESONANCE IMAGING OF THE TIBIA TRABECULAR BONE STRUCTURE
J. Marques1,2, E. Dam2. 1Univ. of Copenhagen, Copenhagen, Denmark;
2BiomedIQ S/A, Rødovre, Denmark
Purpose: Degradation of the articular cartilage and overall bone
remodeling are the main effects of Osteoarthritis (OA) progression.
Magnetic resonance imaging (MRI) has helped experts to diagnose OA
by providing methods for quantiﬁcation the multiple components of the
knee joint and detecting early tissue changes. A recent advance in OA
quantiﬁcation is the automatic measurement of the cartilage volume
using MRI scans. We analyzed MRI scans to investigate the feasibility of
predicting the rapid/slow progressors of tibial cartilage loss by a fully
automatic quantiﬁcation of the trabecular tibia bone structure.
Methods: The longitudinal study included 159 subjects from a
community-based, non-treatment study. The data set consisted of 268
knee MRI, after exclusion of scans due to the subjects that dropped out
in the follow-up or to acquisition errors. The population characteristics
were: age 56±16, Body Mass Index 26±4, 47% female, and 19% with
radiographic OA (Kellgren Lawrence grade, KLG > 1). The KLG was
determined from load-bearing radiographs in semi-ﬂexed position using
the SynaFlex (Synarc). MRI scans were acquired using a Turbo 3D T1
